|
π
|
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
22 auth.
M. Cruts,
I. Gijselinck,
J. Zee,
S. Engelborghs,
H. Wils,
D. Pirici,
R. Rademakers,
R. Vandenberghe,
B. Dermaut,
Jean-Jacques Martin,
...
C. Duijn,
K. Peeters,
R. Sciot,
P. Santens,
T. D. Pooter,
Maria Mattheijssens,
M. Broeck,
Ivy Cuijt,
K. Vennekens,
P. Deyn,
S. Kumar-Singh,
C. Broeckhoven
|
10 |
2006 |
10
π
|
|
π
|
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
12 auth.
A. Oosterom,
I. Judson,
J. Verweij,
S. Stroobants,
E. D. Paola,
S. DimitrijeviΔ,
...
M. Martens,
A. Webb,
R. Sciot,
M. Glabbeke,
S. Silberman,
O. S. Nielsen
|
10 |
2001 |
10
π
|
|
π
|
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
32 auth.
Bert Oosthuyse,
L. Moons,
E. Storkebaum,
H. Beck,
D. Nuyens,
K. Brusselmans,
J. Dorpe,
P. Hellings,
M. Gorselink,
S. Heymans,
G. Theilmeier,
M. Dewerchin,
V. Laudenbach,
P. Vermylen,
H. Raat,
...
T. Acker,
V. Vleminckx,
L. Bosch,
N. Cashman,
H. Fujisawa,
M. Drost,
R. Sciot,
F. Bruyninckx,
D. Hicklin,
C. Ince,
P. Gressens,
F. Lupu,
K. Plate,
W. Robberecht,
J. Herbert,
D. Collen,
P. Carmeliet
|
10 |
2001 |
10
π
|
|
π
|
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
10 auth.
G. Van Assche,
M. Van Ranst,
R. Sciot,
B. Dubois,
S. Vermeire,
M. Noman,
...
J. Verbeeck,
K. Geboes,
W. Robberecht,
P. Rutgeerts
|
9 |
2005 |
9
π
|
|
π
|
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.
15 auth.
M. Debiec-Rychter,
R. Sciot,
A. Le Cesne,
M. Schlemmer,
P. Hohenberger,
A. V. van Oosterom,
J. Blay,
S. Leyvraz,
M. Stul,
P. Casali,
...
J. Zalcberg,
J. Verweij,
M. V. Van Glabbeke,
A. Hagemeijer,
I. Judson
|
9 |
2006 |
9
π
|
|
π
|
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
59 auth.
J. Blay,
S. Bonvalot,
P. Casali,
Haesun Choi,
M. Debiec-Richter,
A. Tos,
J. Emile,
A. Gronchi,
P. Hogendoorn,
H. Joensuu,
A. Cesne,
Joan Mac Clure,
J. Maurel,
Ninna Nupponen,
I. Ray-Coquard,
...
P. Reichardt,
R. Sciot,
S. Stroobants,
M. Glabbeke,
A. Oosterom,
G. Demetri,
Ianis Boukovinas,
P. Meeus,
J. Janinis,
Rosella Bertulli,
M. Colecchia,
A. Messina,
E. Tamborini,
Seiichi Hirota,
T. Nishida,
J. Martin,
A. Poveda,
R. Ramos,
L. Guillou,
S. Leyvraz,
M. Leahy,
C. Corless,
R. DeMatteo,
J. Zalcberg,
Dolores Knufer,
Aage Schultz,
I. Judson,
B. Fervers,
B. Bui,
F. Coevorden,
R. S. Benjamin,
R. Maki,
J. Verweij,
O. S. Nielsen,
M. Heinrich,
B. V. Geel,
L. Baker,
M. Mehren,
T. AlvegΓ₯rd,
J. Coindre,
K. Antman,
P. Hohenberger,
K. Sundby-Hall,
P. Rutkowski
|
9 |
2005 |
9
π
|
|
π
|
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
17 auth.
M. Ladanyi,
Man Yee Lui,
C. Antonescu,
A. Krause-Boehm,
A. Meindl,
P. Argani,
J. Healey,
T. Ueda,
Hiroumi Yoshikawa,
A. Meloni-Ehrig,
...
P. Sorensen,
F. Mertens,
N. Mandahl,
H. Berghe,
R. Sciot,
P. Cin,
J. Bridge
|
9 |
2001 |
9
π
|
|
π
|
Somatic mosaic IDH1 or IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
27 auth.
T. Pansuriya,
R. van Eijk,
Pio d' Adamo,
M. V. van Ruler,
M. Kuijjer,
J. Oosting,
A. Cleton-Jansen,
J. V. van Oosterwijk,
S. Verbeke,
D. Meijer,
T. van Wezel,
K. H. Nord,
L. Sangiorgi,
B. Toker,
B. Liegl-Atzwanger,
...
Mikel San-JuliΓ‘n,
R. Sciot,
N. Limaye,
L. Kindblom,
S. Daugaard,
C. Godfraind,
L. Boon,
M. Vikkula,
K. Kurek,
K. Szuhai,
P. French,
J. BovΓ©e
|
8 |
2011 |
8
π
|
|
π
|
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.
13 auth.
M. Debiec-Rychter,
J. Cools,
H. Dumez,
R. Sciot,
M. Stul,
N. Mentens,
H. Vranckx,
B. WasΔ
g,
H. Prenen,
J. Roesel,
...
A. Hagemeijer,
A. V. van Oosterom,
P. Marynen
|
8 |
2005 |
8
π
|
|
π
|
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.
14 auth.
M. Debiec-Rychter,
H. Dumez,
I. Judson,
B. WasΔ
g,
J. Verweij,
M. Brown,
S. DimitrijeviΔ,
R. Sciot,
M. Stul,
H. Vranck,
...
M. Scurr,
A. Hagemeijer,
M. Glabbeke,
A. Oosterom
|
8 |
2004 |
8
π
|
|
π
|
Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
28 auth.
Ana Rita Pombo Antunes,
Isabelle Scheyltjens,
F. Lodi,
J. Messiaen,
A. Antoranz,
J. Duerinck,
Daliya Kancheva,
L. Martens,
Karen De Vlaminck,
Hannah Van Hove,
Signe Schmidt KjΓΈlner Hansen,
F. Bosisio,
K. Van der Borght,
S. De Vleeschouwer,
R. Sciot,
...
L. Bouwens,
M. Verfaillie,
N. Vandamme,
R. Vandenbroucke,
O. De Wever,
Y. Saeys,
M. Guilliams,
C. Gysemans,
B. Neyns,
F. De Smet,
D. Lambrechts,
J. V. Van Ginderachter,
K. Movahedi
|
8 |
2021 |
8
π
|
|
π
|
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.
13 auth.
P. Rutkowski,
M. V. Van Glabbeke,
C. Rankin,
W. Ruka,
B. Rubin,
M. Debiec-Rychter,
A. Lazar,
H. Gelderblom,
R. Sciot,
D. Lopez-Terrada,
...
P. Hohenberger,
A. V. van Oosterom,
S. Schuetze
|
8 |
2010 |
8
π
|
|
π
|
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
24 auth.
M. Tanas,
A. Sboner,
A. Oliveira,
M. Erickson-Johnson,
J. Hespelt,
P. Hanwright,
J. Flanagan,
Yongde Luo,
K. Fenwick,
R. Natrajan,
...
C. Mitsopoulos,
M. Zvelebil,
B. Hoch,
S. Weiss,
M. Debiec-Rychter,
R. Sciot,
R. West,
A. Lazar,
A. Ashworth,
J. Reis-Filho,
C. Lord,
M. Gerstein,
M. Rubin,
B. Rubin
|
8 |
2011 |
8
π
|
